Pieris' Series B Round

Pieris raised a round of funding on March 27, 2008.

Pieris is an independent, clinical-staged biotechnology company advancing its proprietary Anticalin technology to create differentiated drugs that are safer and more effective than conventional approa…

Articles about Pieris' Series B Round: